Furthermore, due to the discordance between HPV serological and tumor status, we determined the tumor HPV16 status for SCCOP patients to further explore the association between these TNF-α promoter variants and susceptibility to HPV-associated SCCOP. This evidence concerns the gene TNF and neoplasm.